Randomized Double-blind Placebo-controlled Trial on Levothyroxine and Liothyronine Combination Therapy in Totally Thyroidectomized Subjects: the Levolio Study.

Six months of combination therapy with twice daily LT3 dose adapted according to TSH-level do not significantly change peripheral tissue response or quality of life, despite an increase in the fT3/fT4 ratio.